Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 1, 1999, Pages 190-193

  Yamanaka, Gregory ^a   Wilson, Todd ^a   Innaimo, Steven ^a   Bisacchi, Gregory S ^a   Egli, Peter ^a   Rinehart, J Kent ^a   Zahler, Robert ^a   Colonno, Richard J ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; ENTECAVIR; GANCICLOVIR; LAMIVUDINE; LOBUCAVIR; PENCICLOVIR; UNCLASSIFIED DRUG;

ARTICLE; CELL METABOLISM; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG TRANSFORMATION; DRUG UPTAKE; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; PHOSPHORYLATION; PRIORITY JOURNAL;

EID: 0032907705     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.1.190     Document Type: Article

References (16)

1. Beasley, R. P., and L. V. Hwang. 1991. Overview on the epidemiology of hepatocellular carcinoma, p. 532-535. In F. B. Hollinger, S. M. Lemon, and M. Margolis (ed.), Viral hepatitis and liver disease. The Williams & Wilkins Co., Baltimore, Md.
2. Bisacchi, G. S., S. T. Chao, C. Bachard, J. P. Daris, S. Innaimo, G. A. Jacobs, O. Kocy, P. Lapointe, A. Martel, Z. Merchant, W. A. Slusarchyk, J. E. Sundeen, M. G. Young, R. Colonno, and R. Zahler. 1997. BMS 200475, a novel carbocyclic 2′-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitro. Bioorg. Med. Chem. Lett. 7:127-132.
3. Cammack, N., P. Rouse, C. L. P. Marr, P. J. Reid, R. E. Boehme, J. A. V. Coates, C. R. Penn, and J. M. Cameron. 1992. Cellular metabolism of (-)enantiomeric 2′-deoxy-3′-thiacytidine. Biochem. Pharmacol. 43:2059-2064.
4. Chang, C.-N., V. Skalski, J. H. Zhou, and Y.-C. Cheng. 1992. Biochemical pharmacology of (+)-and (-)-2′,3′-dideoxy-3′-thiacytidine as anti-hepatitis B virus agents. J. Biol. Chem. 267:22414-22420.
5. Earnshaw, D. L., T. H. Bacon, S. J. Darlison, K. Edmonds, R. M. Perkins, R. A. Vere Hodge. 1992. Model of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus. Antimicrob. Agents Chemother. 36:2747-2757.
6. Elion, G. B., A. P. Furman, J. A. Fyfe, P. DeMiranda, L. Beauchamp, and H. J. Schaeffer. 1977. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine. Proc. Natl. Acad. Sci. USA 74:5716-5720.
7. Greenberg, M. L., H. S. Allaudeen, and M. S. Hershfield. 1990. Metabolism, toxicity and anti-HIV activity of 2′-deoxy-3′-thiacytidine (BCH-189) in T and B cell lines. Ann. N. Y. Acad. Sci. 616:517-518.
8. g. Innaimo, S. F., M. Seifer, G. S. Bisacchi, D. N. Standring, R. Zahler, and R. J. Colonno. 1997. Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus. Antimicrob. Agents Chemother. 41:1444-1448.
9. Innaimo, S. F., M. Seifer, E. Genovesi, J. Clark, G. Yamanaka, R. Hamatake, B. Terry, D. Standring, G. Bisacchi, J. Sundeen, R. Zahler, and R. J. Colonno. 1996. Identification of BMS-200475 as a novel and potent inhibitor of hepatitis B virus, abstr. H24. In Abstracts of The 36th Interccience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
10. Keller, P. M., S. A. McKee, and J. A. Fyfe. 1985. Cytoplasmic 5′-nucleotidase catalyzes acyclovir phosphorylation. J. Biol. Chem. 260:8664-8667.
11. Sells, M. A., M-L. Chen, and G. Acs. 1987. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA 84:1005-1009.
12. Sells, M. A., A. Z. Zelent, M. Shvartsman, and G. Acs. 1988. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J. Virol. 62:2836-2844.
13. Slusarchyk, W. A., A. K. Field, J. A. Greytok, P. Taunk, A. V. Tuomari, M. G. Young, and R. Zahler. 1992. 4-Hydroxy-3-(hydroxymethyl)-2-methylenecy-clopentyl purines and pyrimidines, a new class of anti-herpesvirus agents. Antiviral Res. 17(Suppl. 1):98.
14. Thackray, A. M., and H. J. Field. 1996. Comparison of effects of famciclovir and valaciclovir on pathogenesis of herpes simplex virus type 2 in a murine infection model. Antimicrob. Agents Chemother. 40:846-851.
15. Vere Hodge, R. A., and R. M. Perkins. 1989. Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells. Antimicrob. Agents Chemother. 33:223-229.
16. Yamanaka, G., A. V. Tuomari, M. Hagen, B. McGeever-Rubin, B. Terry, M. Haffey, G. S. Bisacchi, and A. K. Field. 1991. Selective activity and cellular pharmacology of (1R-1α,2β,3α)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells. Mol. Pharmacol. 40:446-453.